UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 266

Sortiert nach

Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia

Leukemia, 2021-09, Vol.35 (9), p.2727-2730

2021

Link zum Volltext

Verfügbarkeit prüfen

The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey

Supportive care in cancer, 2021-12, Vol.29 (12), p.7591-7599

2021

Link zum Volltext

Verfügbarkeit prüfen

Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents

Cancers, 2021-10, Vol.13 (20), p.5141

2021

Link zum Volltext

Verfügbarkeit prüfen

Nodal marginal zone lymphoma: clinical features, diagnosis, management and treatment

Best practice & research. Clinical haematology, 2017-03, Vol.30 (1-2), p.92-98

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Haematologica (Roma), 2022-03, Vol.107 (3), p.625

2022

Link zum Volltext

Verfügbarkeit prüfen

Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy

Leukemia & lymphoma, 2015-07, Vol.56 (7), p.1949-1958

2015

Link zum Volltext

Verfügbarkeit prüfen

Discordant bone marrow involvement in non-Hodgkin lymphoma

Blood, 2016-02, Vol.127 (8), p.965-970

2016

Link zum Volltext

Verfügbarkeit prüfen

The Involvement of LAG-3positive Plasma Cells in the Development of Multiple Myeloma

International journal of molecular sciences, 2023-12, Vol.25 (1), p.549

2023

Link zum Volltext

Verfügbarkeit prüfen

Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway

PloS one, 2020-03, Vol.15 (3), p.e0230033-e0230033

2020

Link zum Volltext

Verfügbarkeit prüfen

Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients

Mayo Clinic proceedings, 2015-06, Vol.90 (6), p.756-764

2015

Link zum Volltext

Verfügbarkeit prüfen

Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia

Frontiers in immunology, 2022-09, Vol.13, p.953644-953644

2022

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of primary splenic diffuse large B‐cell lymphoma and role of splenectomy in improving survival

Cancer, 2015-09, Vol.121 (17), p.2909-2916

2015

Link zum Volltext

Verfügbarkeit prüfen

Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era

Haematologica (Roma), 2014-01, Vol.99 (1), p.125

2014

Link zum Volltext

Verfügbarkeit prüfen

Time to Cure Hairy Cell Leukemia

Turkish journal of haematology, 2017-12, Vol.34 (4), p.289-290

2017

Link zum Volltext

Verfügbarkeit prüfen

Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study

Annals of hematology, 2020-06, Vol.99 (6), p.1273-1281

2020

Link zum Volltext

Verfügbarkeit prüfen

Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy

Palliative medicine, 2021-05, Vol.35 (5), p.927-932

2021

Link zum Volltext

Verfügbarkeit prüfen

A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity

PloS one, 2019-01, Vol.14 (1), p.e0209024-e0209024

2019

Link zum Volltext

Verfügbarkeit prüfen

P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998‐2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS

HemaSphere, 2023-08, Vol.7 (S3), p.e944666d-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

P1532: CLINICAL OUTCOMES OF COVID‐19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)

HemaSphere, 2023-08, Vol.7 (S3), p.e96550ad-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia

Frontiers in immunology, 2021-02, Vol.11, p.603569-603569

2021

Link zum Volltext

Verfügbarkeit prüfen

It’s time to change the standard of care for hairy cell leukemia?

Leukemia & lymphoma, 2024-07, p.1-3

2024

Link zum Volltext

Verfügbarkeit prüfen

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion

Cancer Immunology, Immunotherapy, 2013-01, Vol.62 (1), p.87-99

2013

Link zum Volltext

Verfügbarkeit prüfen

Hierarchical involvement of myeloid derived suppressor cells and monocytes expressing latency-associated peptide in plasma cell dyscrasias

Turkish journal of haematology, 2018-01, Vol.35 (2), p.116-121

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 266

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(250)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(166)
Humans
(139)
Hematology
(134)
Oncology
(93)
Female
(78)
Male
(74)
Aged
(56)
Middle Aged
(49)
Adult
(40)
Prognosis
(37)
Chronic Lymphocytic Leukemia
(33)
Retrospective Studies
(32)
Leukemia
(30)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(30)
Treatment Outcome
(30)
Aged, 80 And Over
(29)
Patients
(28)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Rituximab
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia

The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey

Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents

Nodal marginal zone lymphoma: clinical features, diagnosis, management and treatment

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy

Discordant bone marrow involvement in non-Hodgkin lymphoma

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

The Involvement of LAG-3positive Plasma Cells in the Development of Multiple Myeloma

Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway

Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients

Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia

Characteristics of primary splenic diffuse large B‐cell lymphoma and role of splenectomy in improving survival

Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era

Time to Cure Hairy Cell Leukemia

Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study

Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy

A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity

P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998‐2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS

P1532: CLINICAL OUTCOMES OF COVID‐19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)

The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia

It’s time to change the standard of care for hairy cell leukemia?

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion

Hierarchical involvement of myeloid derived suppressor cells and monocytes expressing latency-associated peptide in plasma cell dyscrasias

Suchergebnisse filtern